Filing Details

Accession Number:
0001267602-15-000084
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-17 16:19:49
Reporting Period:
2015-12-15
Filing Date:
2015-12-17
Accepted Time:
2015-12-17 16:19:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267602 Alimera Sciences Inc ALIM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1374256 Jr S Richard Eiswirth 6120 Windward Parkway, Suite 290
Alpharetta GA 30005
Coo And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-15 31,260 $1.33 66,234 No 4 M Direct
Common Stock Disposition 2015-12-15 31,260 $2.32 34,974 No 4 S Direct
Common Stock Acquisiton 2015-12-16 15,409 $1.33 50,383 No 4 M Direct
Common Stock Disposition 2015-12-16 15,409 $2.30 34,974 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2015-12-15 31,260 $0.00 31,260 $1.33
Common Stock Employee Stock Option (Right to Buy) Disposition 2015-12-16 15,409 $0.00 15,409 $1.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,409 2016-01-01 No 4 M Direct
0 2016-01-01 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2015.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.24 to $2.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.17 to $2.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
  4. Became exercisable with respect to 1/4 of the shares of stock which are subject to this option on 10/31/06 (the "Initial Vesting Date") and with respect to the remainder of the shares in equal increments quarterly over three years beginning on the date three (3) months from the Initial Vesting Date.